Adrian M. Di Bisceglie
#180,563
Most Influential Person Now
Adrian M. Di Bisceglie's AcademicInfluence.com Rankings
Adrian M. Di Biscegliemedical Degrees
Medical
#3740
World Rank
#4246
Historical Rank
Gastroenterology
#90
World Rank
#93
Historical Rank
Adrian M. Di Biscegliephilosophy Degrees
Philosophy
#11301
World Rank
#15548
Historical Rank
Logic
#8113
World Rank
#10098
Historical Rank
Download Badge
Medical Philosophy
Adrian M. Di Bisceglie's Degrees
- Doctorate Medicine University of Buenos Aires
Why Is Adrian M. Di Bisceglie Influential?
(Suggest an Edit or Addition)Adrian M. Di Bisceglie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions (1999) (3581)
- Hepatitis C and Hepatocellular Carcinoma (1995) (502)
- Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features (1995) (264)
- Hepatitis B and hepatocellular carcinoma (2009) (215)
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg? (2015) (207)
- Natural history of hepatitis C: its impact on clinical management. (2000) (203)
- Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease (2003) (167)
- Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status (2003) (153)
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C (2012) (119)
- Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network (2015) (110)
- Issues in screening and surveillance for hepatocellular carcinoma. (2004) (104)
- Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA (1995) (103)
- Up‐regulation of circulating miR‐20a is correlated with hepatitis C virus‐mediated liver disease progression (2013) (102)
- Epidemiology and clinical presentation of hepatocellular carcinoma. (2002) (86)
- Histological evaluation of iron in liver biopsies: relationship to HFE mutations (2000) (83)
- Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. (2003) (71)
- 13 Hepatitis C and hepatocellular carcinoma (2000) (71)
- Comprehensive Clinical Hepatology (2000) (70)
- Original ContributionsNonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions (1999) (61)
- Hepatitis G virus infection: a work in progress. (1996) (45)
- Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C (2001) (43)
- Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis (1993) (40)
- Spontaneous bacterial peritonitis caused by infection with Listeria monocytogenes: a case report and review of the literature (1998) (40)
- 1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY (2009) (37)
- Liver transplantation for hepatitis C: The promise and the challenge (1995) (36)
- Hepatitis delta virus: Molecular biology, pathogenesis, and clinical aspects (1993) (33)
- Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg (1996) (32)
- Cirrhosis and chronic pancreatitis in alcoholics. (1984) (32)
- Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease (2012) (31)
- Randomized Controlled Trial of a Four Month Course of Recombinant Human Alpha Interferon in Patients with Chronic Type B Hepatitis (1987) (29)
- Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C (1995) (21)
- Chronic hepatitis C viral infection in patients with normal serum alanine aminotransferases. (1999) (21)
- Liver Disease: Diagnosis and Management (1999) (20)
- Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. (1989) (19)
- Interferon therapy of chronic viral hepatitis. (1994) (18)
- Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C (2012) (16)
- Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female (2016) (16)
- Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers (1987) (15)
- Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes? (2005) (14)
- Hepatitis C—virology and future antiviral targets (1999) (14)
- What every hepatologist should know about endocrinology: obesity, diabetes, and liver disease. (2004) (13)
- Hepatitis C (1998) (13)
- A DESCRIPTIVE STUDY OF THE RELATIONSHIP BETWEEN MOOD DISORDERS AND HEPATITIS C TREATMENT COMPLIANCE: DOES NURSING PLAY A ROLE? (2004) (13)
- Combination therapy for hepatitis C. (2002) (13)
- Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy (2016) (12)
- Tumors and Cysts of the Liver (2010) (12)
- Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals (2019) (11)
- Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B. (1995) (10)
- Liver Transplantation in Patients with Chronic Hepatitis C and Alcoholism (1999) (9)
- Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study (2001) (9)
- Design of the halt-C trial (Hepatitis C antiviral long-term treatment to prevent Cirrhosis) (2000) (9)
- Screening for Hepatocellular Carcinoma: Being Old is not All Bad (2004) (9)
- Procarbazine‐Induced Hepatotoxicity: Case Report and Review of the Literature (2010) (7)
- Interferon therapy of complicated hepatitis B virus infection. (1989) (7)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Des--Carboxy Prothrombin and -Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma (2010) (6)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease (2009) (6)
- SEN and sensibility: interactions between newly discovered and other hepatitis viruses? (2001) (5)
- Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis (1994) (5)
- Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity. (1996) (5)
- Preventive strategies for chronic liver disease. (2001) (4)
- Liver biopsies in patients with lysosomal storage disease: Experience with effective sedation (1997) (3)
- Acute Exacerbation of Liver Interferon Alfa Therapy for Hepatitis C 1 Disease Chronic During (1992) (3)
- Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET (2017) (3)
- in patients with hepatitis C Plasma chemokine levels correlate with the outcome of antiviral therapy (2013) (3)
- Hepatocellular Cancer: Diagnosis and Treatment (2005) (2)
- Pulmonary Hypertension in a Patient with Non-cirrhotic Portal Hypertension and Scleroderma Sine Scleroderma: A Case Report (2016) (2)
- Thymus-Derived Peptides for Chronic Viral Hepatitis: Have They Fulfilled Their Promise? (1996) (2)
- Effect of dietary iron loading in chimpanzees with chronic hepatitis C virus infection (1998) (2)
- THE UNMET CHALLENGES (1999) (2)
- 237 Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial (2010) (2)
- Chapter 27 – Hepatic tumors (2004) (2)
- Treatment of hepatocellular carcinoma (2002) (2)
- Compartmentalization of hepatitis C viral quasispecies (2003) (1)
- Chronic hepatitis B. Hope for decreasing its impact. (1995) (1)
- Recombinant human α-interferon: A promissory note in non-A, non-B chronic hepatitis (1987) (1)
- CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C (2006) (1)
- Concurrence of steatohepatitis with chronic hepatitis C and other chronic liver diseases (2001) (1)
- T1966 Patient Mortality and Liver Transplantation During the Halt-C Trial: Relationship to Chronic Liver Disease and Interferon Therapy (2010) (1)
- Hepatitis C and hepatocellular carcinoma in African Americans (2000) (1)
- Hepatitis C Patients Naive , Resting Phenotype in a Subset of Accumulation of B Lymphocytes with a Rice (2003) (1)
- Sample size in trials of hepatitis C. Author's reply (2002) (1)
- Hepatitis C Virus (1999) (1)
- THU-182-The PRIORITIZE study: A pragmatic, randomized study of oral regimens for hepatitis C-transforming decision-making for patients, providers, and stakeholders (2019) (1)
- P0908 : Adherence to ombitasvir/paritaprevir/r, dasabuvir, and ribavirin is >98% in the Sapphire-I and Sapphire-II trials (2015) (1)
- Tumors of the Liver (2004) (0)
- Print and Media ReviewCurbside Consultation of the Liver: 49 Clinical Questions, $79.95 , Mitchell L. Shiffman (Ed.), SLACK, Inc, Thorofare, New Jersey (2008), p. 245, ISBN 1-5564-2815-4. Web site for ordering: www.slackbooks.com (2009) (0)
- Chapter 16 – Hepatitis C (2006) (0)
- Abstract 5724: Circulatory microRNA expression profiling between HCV-infected African & Caucasian Americans: implications for racial health disparities (2017) (0)
- Changes in Levels of HCV-RNA and Hepatitis C Viral Antigen Associated with Interferon-alpha Therapy of Chronic Hepatitis C (1994) (0)
- Does bare-stent TIPS increase the risk of hepatocellular carcinoma in patients with cirrhosis? (2005) (0)
- Benign Tumors, Nodules, and Cystic Diseases of the Liver (2011) (0)
- CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C (2007) (0)
- , Brian I. Carr (Ed.). Humana Press, Totowa, New Jersey (2005), www.humanapress.com, Web address for ordering: (2005) (0)
- The AASLD and public policy: Coming in out of the cold† (2007) (0)
- Therapy of Hepatitis C (2007) (0)
- Abstract IA37: Prevention of Hepatocellular Carcinoma (HCC) with antiviral therapy (2017) (0)
- Meet Your President: Michael W. Fried, M.D., F.A.A.S.L.D. (2019) (0)
- Su1574 - Evaluation of Serum-Derived Immunoglobulin Protein Isolate in Subjects with Decompensated Cirrhosis and Ascites (2018) (0)
- Contents, Vol. 14, 1996 (1992) (0)
- Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet? (2014) (0)
- Abstract 1085: Serum miR-30e and miR-223 are promising non-invasive biomarkers for hepatocellular carcinoma (2016) (0)
- Hepatitis C virus genotype 4 infection in the United States; Clinical features and response to therapy (2001) (0)
- Prevalence, natural history, and management of suspected barrett’s esophagus in patients with cirrhosis (2018) (0)
- CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C (2010) (0)
- 382 ASSOCIATION BETWEEN IMMUNOHISTOCHEMICAL STAINING FOR HBV ANTIGENS IN LIVER BIOPSIES AND CIRCULATING HBV DNA AND OTHER CHARACTERISTICS OF HBV VIRAL INFECTION (2020) (0)
- Su1514 – Differences in Clinical and Serologic Characterization of Acute and Chronic Hepatitis B in North America: Analysis of the Hepatitis B Research Network (2019) (0)
- Subject Index Vol. 14, 1996 (1996) (0)
- Chapter 29 – Hepatic Tumors (2018) (0)
- This information is current as Cytolysis by Hepatitis C Virus Inhibition of Complement-Dependent Distinct CD 55 Isoform Synthesis and Di Bisceglie (2016) (0)
- Prevention of hepatocellular carcinoma with antiviral therapy. (2018) (0)
- Book Review Malignant Liver Tumors: Current and Emerging Therapies Second edition. Edited by Pierre A. Clavien, Yuman Fong, H. Kim Lyerly, Michael A. Morse, and Alan P. Venook. 482 pp., illustrated. Sudbury, Mass., Jones and Bartlett, 2004. $174.95. 0-7637-1857-2 (2004) (0)
- Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis q,qq (2007) (0)
- S1895 Impact of Adjuvant Chemotherapy on Hepatitis C Virus Reactivation and Tumor Recurrence in Patients With Hepatitis C-Related Hepatocellular Carcinoma (HCC) Undergoing Liver Transplantation (2010) (0)
- Pulmonary Arterial Hypertension in a Patient With Noncirrhotic Portal Hypertension (2013) (0)
- SAT-454-Management of hepatocellular carcinoma in a real life multinational, longitudinal, observational study (TARGET-HCC) (2019) (0)
This paper list is powered by the following services:
